Equetro

Equetro is a brand name of carbamazepine, approved by the FDA in the following formulation(s):

EQUETRO (carbamazepine - capsule, extended release; oral)

• 
  Manufacturer: VALIDUS PHARMS INC
  
  Approval date: December 10, 2004
  
  Strength(s): 100MG, 200MG, 300MG ^[RLD]

Has a generic version of Equetro been approved?

No. There is currently no therapeutically equivalent version of Equetro available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Equetro. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine
  Patent 5,326,570
  Issued: July 5, 1994
  Inventor(s): Rudnic; Edward M. & Belendiuk; George W.
  Assignee(s): Pharmavene, Inc.
  The present invention relates to a composition and method of treating a patient by administering carbamazepine in a pharmaceutical dosage form capable of maintaining the patient's blood concentration at from about 4 .mu.g/ml to about 12 .mu.g/ml over at least a 12 hour period, where the blood concentration of carbamazepine does not vary by more than 60 percent.
  
  Patent expiration dates:
  
  
  • July 23, 2011
    
    ✓ 
    Patent use: TREATMENT OF PATIENTS USING EXTENDED-RELEASE CARBAMAZEPINE
    ✓ 
    Drug product
  
  



• 
  Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine
  Patent 5,912,013
  Issued: June 15, 1999
  Inventor(s): Rudnic; Edward M. & Belendiuk; George W. & McCarty; John & Wassink; Sandra & Couch; Richard A.
  Assignee(s): Shire Laboratories, Inc.
  The present invention relates to a composition and method of treating a patient by administering carbamazepine in a pharmaceutical dosage form capable of maintaining the patient's blood concentration at from about 4 .mu.g/ml to about 12 .mu.g/ml over at least a 12 hour period, where the blood concentration of carbamazepine does not vary by more than 60 percent.
  
  Patent expiration dates:
  
  
  • June 15, 2016
    
    ✓ 
    Drug product
  
  



• 
  Methods for the treatment of bipolar disorder using carbamazepine
  Patent 6,977,253
  Issued: December 20, 2005
  Inventor(s): Kalali; Amir H. & Tulloch; Simon J.
  Assignee(s): Shire Pharmaceutical Development Inc.
  Carbamazepine, in extended release form, is useful in the treatment of patients suffering from bipolar disorder. In order to minimize the time it takes to reach efficacy, carbamazepine, in extended release form, can be administered to the patient at an initial daily dose which is then increased in daily increments until clinical efficacy is achieved.
  
  Patent expiration dates:
  
  
  • May 19, 2024
    
    ✓ 
    Patent use: THE RECOMMENDED INITIAL DOSE OF EQUETRO IS 400MG/DAY GIVEN IN DIVIDED DOSES, TWICE DAILY. THE DOSE SHOULD BE ADJUSTED IN 200MG DAILY INCREMENTS TO ACHIEVE OPTIMAL CLINICAL RESPONSE.
  
  

See also...

• Equetro Consumer Information (Drugs.com)
• Equetro Sustained-Release Capsules Consumer Information (Wolters Kluwer)
• Equetro Consumer Information (Cerner Multum)
• Equetro Advanced Consumer Information (Micromedex)
• Carbamazepine Consumer Information (Drugs.com)
• Carbamazepine Consumer Information (Wolters Kluwer)
• Carbamazepine Chewable Tablets Consumer Information (Wolters Kluwer)
• Carbamazepine Suspension Consumer Information (Wolters Kluwer)
• Carbamazepine Sustained-Release Capsules Consumer Information (Wolters Kluwer)
• Carbamazepine Sustained-Release Tablets Consumer Information (Wolters Kluwer)
• Carbamazepine Consumer Information (Cerner Multum)
• Carbamazepine Advanced Consumer Information (Micromedex)
• Carbamazepine AHFS DI Monographs (ASHP)

Risperidon TAD

Risperidon TAD may be available in the countries listed below.

Ingredient matches for Risperidon TAD

Risperidone

Risperidone is reported as an ingredient of Risperidon TAD in the following countries:

• Germany


• Poland

International Drug Name Search

Doxydyn

Doxydyn may be available in the countries listed below.

Ingredient matches for Doxydyn

Doxycycline

Doxycycline hyclate (a derivative of Doxycycline) is reported as an ingredient of Doxydyn in the following countries:

• Austria

International Drug Name Search

Piridoksin

Piridoksin may be available in the countries listed below.

Ingredient matches for Piridoksin

Pyridoxine

Pyridoxine hydrochloride (a derivative of Pyridoxine) is reported as an ingredient of Piridoksin in the following countries:

• Serbia

International Drug Name Search

Aluminium Oxide

ATC (Anatomical Therapeutic Chemical Classification)

D10AX04

CAS registry number (Chemical Abstracts Service)

0001344-28-1

Chemical Formula

Al2-O3

Molecular Weight

101

Therapeutic Categories

Dermatological agent

Pharmaceutic aid

Antiacne agent for topical use

Chemical Name

Aluminium oxide

Foreign Names

• Aluminii oxidum (Latin)
• Aluminiumoxid (German)
• Aluminium, oxyde d' (French)
• αxido de aluminio (Spanish)

Generic Names

• Alumina (IS)
• Aluminium oxyde (IS: ATC)
• Alumina, activated (IS)
• Aluminii oxidum hydricum (PH: Ph. Eur. 6)
• Aluminium oxide, hydrated (PH: Ph. Eur. 6)
• Aluminiumoxid, wasserhaltiges (PH: Ph. Eur. 6)
• Dried Aluminium Hydroxide (PH: BP 2010)
• Oxyde d'aluminium, hydraté (PH: Ph. Eur. 6)

Brand Name

• Rocgel
  Dexo, France

International Drug Name Search

Glossary

IS	Inofficial Synonym
PH	Pharmacopoeia Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Apo-Prochlorazine

Apo-Prochlorazine may be available in the countries listed below.

Ingredient matches for Apo-Prochlorazine

Prochlorperazine

Prochlorperazine maleate (a derivative of Prochlorperazine) is reported as an ingredient of Apo-Prochlorazine in the following countries:

• Canada

International Drug Name Search

Dolgesik

Dolgesik may be available in the countries listed below.

Ingredient matches for Dolgesik

Tramadol

Tramadol hydrochloride (a derivative of Tramadol) is reported as an ingredient of Dolgesik in the following countries:

• Indonesia

International Drug Name Search

Kemadren

Kemadren may be available in the countries listed below.

Ingredient matches for Kemadren

Procyclidine

Procyclidine hydrochloride (a derivative of Procyclidine) is reported as an ingredient of Kemadren in the following countries:

• Spain

International Drug Name Search

Merional

Merional may be available in the countries listed below.

Ingredient matches for Merional

Menotropins

Menotropins is reported as an ingredient of Merional in the following countries:

• Czech Republic


• Greece


• Hungary


• Oman


• Serbia


• Slovakia


• Switzerland


• Turkey


• United Kingdom

International Drug Name Search

Myclav

Myclav may be available in the countries listed below.

Ingredient matches for Myclav

Amoxicillin

Amoxicillin is reported as an ingredient of Myclav in the following countries:

• India

Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Myclav in the following countries:

• Georgia


• Oman


• Sri Lanka

Clavulanate

Clavulanic Acid is reported as an ingredient of Myclav in the following countries:

• Georgia


• India


• Sri Lanka

Clavulanic Acid potassium (a derivative of Clavulanic Acid) is reported as an ingredient of Myclav in the following countries:

• Oman

International Drug Name Search

Mycospor

Mycospor may be available in the countries listed below.

Ingredient matches for Mycospor

Bifonazole

Bifonazole is reported as an ingredient of Mycospor in the following countries:

• Aruba


• Australia


• Bahamas


• Bahrain


• Barbados


• Belize


• Bermuda


• Brazil


• Cayman Islands


• China


• Colombia


• Costa Rica


• Cyprus


• Czech Republic


• Dominican Republic


• Ecuador


• Egypt


• El Salvador


• Georgia


• Germany


• Greece


• Guatemala


• Haiti


• Honduras


• Hong Kong


• Hungary


• Indonesia


• Iran


• Jamaica


• Japan


• Jordan


• Kenya


• Kuwait


• Lebanon


• Luxembourg


• Mexico


• Netherlands


• Netherlands Antilles


• Nicaragua


• Oman


• Panama


• Peru


• Poland


• Portugal


• Qatar


• Romania


• Russian Federation


• Saudi Arabia


• Slovakia


• Slovenia


• South Africa


• Spain


• Sudan


• Suriname


• Taiwan


• Tanzania


• Trinidad & Tobago


• Turkey


• Uganda


• United Arab Emirates

International Drug Name Search

Clonidin retard-ratiopharm

Clonidin retard-ratiopharm may be available in the countries listed below.

Ingredient matches for Clonidin retard-ratiopharm

Clonidine

Clonidine hydrochloride (a derivative of Clonidine) is reported as an ingredient of Clonidin retard-ratiopharm in the following countries:

• Germany

International Drug Name Search

Kinetix

Kinetix may be available in the countries listed below.

Ingredient matches for Kinetix

Mosapride

Mosapride is reported as an ingredient of Kinetix in the following countries:

• India

International Drug Name Search

Naprogen

Naprogen may be available in the countries listed below.

Ingredient matches for Naprogen

Naproxen

Naproxen is reported as an ingredient of Naprogen in the following countries:

• Argentina

International Drug Name Search

Moxon

Moxon may be available in the countries listed below.

Ingredient matches for Moxon

Moxonidine

Moxonidine is reported as an ingredient of Moxon in the following countries:

• Belgium


• Luxembourg


• Portugal


• Spain

International Drug Name Search